Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study

PURPOSE: To evaluate whether quantitative whole-body (WB) PSMA-PET metrics under long-term androgen deprivation therapy (ADT) and/or androgen receptor signaling inhibitors (ARSi) are associated with PSA progression. METHODS: Patients who underwent at least 2 (68)Ga-PSMA-11 PET/CT scans between Octob...

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Vishnu, Appiah-Kubi, Emmanuel, Nguyen, Kathleen, Thin, Pan, Hotta, Masatoshi, Shen, John, Drakaki, Alexandra, Rettig, Matthew, Gafita, Andrei, Calais, Jeremie, Sonni, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542625/
https://www.ncbi.nlm.nih.gov/pubmed/37779132
http://dx.doi.org/10.1186/s41824-023-00178-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542625/
https://www.ncbi.nlm.nih.gov/pubmed/37779132
http://dx.doi.org/10.1186/s41824-023-00178-1

Ejemplares similares